← Eichor
Condition: Malignant Lesions Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Lesions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Phase N/A · 1 location(s) · Mayo Clinic · NCT06117930
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
Phase N/A · 1 location(s) · University of Minnesota · NCT07649031
Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment
Phase 1/Phase 2 · 1 location(s) · NanoRay Biotech Co., Ltd. · NCT04807257
Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05178472
Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
NA · 2 location(s) · Alpha Tau Medical LTD. · NCT04068155
Photo-Acoustic and Ultrasonographic Mammoscope
Phase 2 · 1 location(s) · Franciscus Gasthuis & Vlietland (Hospital) · NCT07492589
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgi
EARLY_Phase 1 · 1 location(s) · Eben Rosenthal · NCT07493447
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00242723
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06939023
Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients With Suspected or Confirmed Mac
NA · 1 location(s) · Comenius University · NCT06842615
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Phase 3 · 1 location(s) · Mayo Clinic · NCT06915727
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Phase N/A · 3 location(s) · Proteocyte Diagnostics Inc. · NCT04622462
An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06718725
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00006518
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01473784
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT04534127
Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05934994
Role of the Dentist in the Control of the Alcoholic Habit in Patients with Potentially Malignant Oral Lesions
NA · 1 location(s) · University of Santiago de Compostela · NCT04584333
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonan
NA · 1 location(s) · Nicole Baca · NCT04763109
Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.
NA · 2 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06397846
Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Sta
NA · 1 location(s) · University Medical Center Groningen · NCT06940505
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Phase N/A · 5 location(s) · Proteocyte Diagnostics Inc. · NCT05853783
To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy
NA · 1 location(s) · Portuguese Oncology Institute, Coimbra · NCT06696209
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Eva
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06878547
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT05687149
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Phase N/A · 3 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT04275557
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Phase N/A · 1 location(s) · California Pacific Medical Center Research Institute · NCT01750619
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.